Funded Projects

ACE 2020-2022: SAVE MOMS

The American Craft Exposition (ACE) is committed to supporting research and clinical programs at NorthShore University HealthSystem (NorthShore). In 2022, ACE is supporting an initiative to protect and preserve the health of pregnant and postpartum women at NorthShore. To make a donation to support these efforts, please click here.

Click on image to enlarge!

Past research projects funded by ACE include:

Mark Drexler, MD and Frederick Miller, MD, PhD

Development and implementation of a Psychiatric Urgent Care Program and Collaborative Care Model.

In 2018 and 2019, ACE supported the creation of a Psychiatric Urgent Care Program and the implementation of a Collaborative Care Model for providing mental health services to families. These programs aim to vastly minimize wait times for patients who are in need of urgent psychiatric care, as well as assist primary care physicians with the management of patients with low to medium risk factors. The Auxiliary of NorthShore University HealthSystem is proud to announce that net proceeds raised over two years for these initiatives total over $1.13 million.

Karen Kaul, MD

Pharmacogenomics research analyzing how patients react to medications based on genetic variants.

Jason Koh, MD

Orthopaedic regenerative medicine research at the NorthShore Orthopaedic Institute.

Karen Kaul, MD

Pharmacogenomics research analyzing how patients react to medications based on genetic variants.

Gustavo Rodriguez, MD

Development of a Progestin-Based Pharmacologic Approach for the Effective Prevention of Ovarian Cancer


Clinical Research Coordinator for Breast and Ovarian Cancer Research


Breast Cancer Research Fellowship

Manjari Dimri, MD

Identification of Oncologic Lesions Involved in Invasive and Refractory Breast Cancer

San Ming Wang, MD

Identifying New Breast Cancer Susceptibility Genes

Jean Hurteau, MD

Progestin and Eicosanoid Combination for Chemoprevention of Ovarian Cancer

Gurumurthy, PhD

hEcd, a Novelmarker for Breast Cancer

Raja Srikumar, PhD

Combinatorial Targeting of ErbB2-HSPop Towards Treatment of ErbB2-related Breast Cancer Tumors

Sofia F. Garcia, Ph.D.

Real-time Symptom Monitoring via Computer Telephony in Patients with Advanced Breast Cancer

Xijin Ge, Ph.D.

Bioinformatics Study on BRCA1 Transcriptional Regulation Mechanisms

Gustavo Rodriguez, MD

Development of a Progestin-Based Chemopreventive Agent for Epithelial Ovarian Cancer

Javier Menendez, MD

Effects of Dietary Fatty Acids in Her-2/neu (erbB-2) Oncogene-Induced Breast Tumorigenesis and Trastuzumab (Herceptin™) Efficacy

David J. Winchester, MD

DNA Microarray Analysis of Multicentric Breast Cancers

Ruth Lupu, MD

Characterization of Heregulin-Induced Activation of HER-2: As A New Molecular target in Breast Cancer

Ruth Lupu, MD

A Possible Prognostic and Therapeutic Value of Cyr61/αvβ3 Integrin

Javier Menendez, MD

Pharmacological Inhibition of Fatty Acid Synthase:A New Therapeutic Approach in Her-2/neu-Overexpressing Breast Cancer

Prem K. Seth, Ph.D.

Gene Therapy for Breast Cancer: Targeting Mutant p53 and TGFβ with Replicating Adenoviruses

Joseph Bass, MD, Ph.D.

Regulation of Receptor Kinase Protooncogene Activity in Breast Cancer Cells

Cheikh Menaa, Ph.D.

Cellular and Molecular Mechanism of Osteoclast Formation and Bone Metastasis Induced by Breast Cancer

David J. Winchester, MD

Endoscopic, Cytologic, and Molecular Analysis of Nipple Aspirates in Women

Susan E. Yount, Ph.D.

Quality of Breast Cancer Care

Stuart Lind, MD

Effects of Coformycin and Adenosine Upon Human Breast Cancer Cells

Douglas Merkel, MD

erbB-2: Clonality and Progression in Recurrence and Metastases

XiaoHe Yang, MD

Breast Cancer Selective and DNA Damage Inducible Caspase 3 Mediated Gene Therapy
A Model of “Tissue Specific and Synchronized Double Hit” Cancer Therapy